|
1
|
Momin ZK, Alame A, Vandergriff T, Thomas C, Nezafati K. Diffuse purpuric eruption in a patient with acute myeloid leukemia. JAAD Case Rep 2023; 41:98-101. [PMID: 37920705 PMCID: PMC10618619 DOI: 10.1016/j.jdcr.2023.09.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2023] Open
Affiliation(s)
- Zoha K. Momin
- Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
| | - Aya Alame
- Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
| | - Travis Vandergriff
- Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
| | - Cristina Thomas
- Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
| | - Kaveh Nezafati
- Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
| |
Collapse
|
|
2
|
Sahu KK, Yanamandra U, Malhotra P. ARA-C RELATED RED EAR SYNDROME. EAR, NOSE & THROAT JOURNAL 2019; 98:169-170. [PMID: 30836786 DOI: 10.1177/0145561319831270] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Kamal Kant Sahu
- 1 Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts, United States
| | - Uday Yanamandra
- 2 Department of Internal Medicine, Clinical Hematology Division, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
| | - Pankaj Malhotra
- 2 Department of Internal Medicine, Clinical Hematology Division, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
| |
Collapse
|
|
3
|
Jain A, Malhotra P, Prakash G, Varma S. "Red Hand Syndrome" Due to Cytarabine in a Case of Mantle Cell Lymphoma. Indian J Hematol Blood Transfus 2016; 32:364-5. [PMID: 27408439 DOI: 10.1007/s12288-016-0634-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2015] [Accepted: 01/05/2016] [Indexed: 11/28/2022] Open
Affiliation(s)
- Ankur Jain
- Department of Hematology, PGIMER Chandigarh, House no. 86, sector-15A, Chandigarh, India
| | - Pankaj Malhotra
- Department of Hematology, 4th floor, Nehru Hospital, PGIMER Chandigarh, Chandigarh, India
| | - Gaurav Prakash
- Department of Hematology, 4th floor, Nehru Hospital, PGIMER Chandigarh, Chandigarh, India
| | - Subhash Varma
- Department of Hematology, 4th floor, Nehru Hospital, PGIMER Chandigarh, Chandigarh, India
| |
Collapse
|
|
4
|
Naito M, Yamamoto T, Hara S, Shimamoto C, Miwa Y. Hemoglobin Value Is the Most Important Factor in the Development of Hand-Foot Syndrome under the Capecitabine Regimen. Chemotherapy 2016; 62:23-29. [DOI: 10.1159/000445866] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2015] [Accepted: 03/29/2016] [Indexed: 11/19/2022]
Abstract
Background: Hand-foot syndrome (HFS) is a common side effect that has a high occurrence rate with capecitabine (Cape) chemotherapy. However, little is known about the risk factors of developing HFS under the Cape regimen. Our aim was to examine these risk factors. Methods: A univariate analysis was used to determine the risk factors associated with developing HFS, and we calculated the effect sizes between the patients who developed HFS compared to those who did not. Results: Of the 52 patients enrolled in our research, 24 (46.2%) developed HFS. This group was significantly associated with hemoglobin (Hb) values (p < 0.001), and the effect size (1.21) was more than moderate. The receiver operating characteristic curve analysis confirmed 12 mg/dl Hb as the best diagnostic cut-off value for developing HFS. The sensitivity and specificity were 75.5 and 88.2%, respectively. Patients who had Hb values of 12 or below who developed HFS had longer median times without HFS compared to patients with high Hb values (115 vs. 75 days, p = 0.30, hazard ratio = 1.42, 95% CI 0.73-2.76) and a greater area under the Kaplan-Meier curves (p < 0.05). Conclusion: This research suggests that the Hb value is an important factor for developing HFS.
Collapse
|